Trials / Unknown
UnknownNCT01785732
Renal Sympathetic Denervation and Insulin Sensitivity (RENSYMPIS Study)
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- The Hospital District of Satakunta · Academic / Other
- Sex
- All
- Age
- 30 Years – 69 Years
- Healthy volunteers
- Not accepted
Summary
Hypertension is a major risk factor for stroke and cardiovascular mortality. Catheter- based renal denervation causes substantial and sustained blood- pressure reduction in patients with resistant hypertension. The purpose of RENSYMPIS is to study the effects of renal denervation on: 1. Cardiovascular function 2. Metabolic factors 3. Inflammatory and endocrine factors 4. Coagulation 5. Sleep
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Renal Denervation | Sympathetic renal denervation via renal arteries |
Timeline
- Start date
- 2013-01-01
- Primary completion
- 2014-01-01
- Completion
- 2016-01-01
- First posted
- 2013-02-07
- Last updated
- 2013-02-11
Locations
1 site across 1 country: Finland
Source: ClinicalTrials.gov record NCT01785732. Inclusion in this directory is not an endorsement.